AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Bendamustine Hydrochloride in South Africa

13 products registered with SAHPRA — 13 active

Brand / ProductReg. No.HolderStatusExpires
RIBEND 2556/26/0452Innovata Pharmaceuticalsactive2 May 2028
RIBEND 10056/26/0453Innovata Pharmaceuticalsactive2 May 2028
OOOMUBEN 25 mg55/26/0657.655Aurogen South Africa (Pty) Ltdactive21 Feb 2028
IBOZARD 25 mg55/26/0655Aurogen South Africa (Pty) Ltdactive21 Feb 2028
IBOZARD 100 mg55/26/0656Aurogen South Africa (Pty) Ltdactive21 Feb 2028
OMUBEN 100 mg55/26/0658.656Aurogen South Africa (Pty) Ltdactive21 Feb 2028
BENDAMUSTINE 180 mg/4 ml DRL56/26/0216Dr ReddyÆs Laboratories (Pty) Ltdactive21 Feb 2028
EQUIBEN 10056/26/0823Equity Pharmaceutical (Pty) Ltdactive7 Feb 2028
EQUIBEN 2556/26/0822Equity Pharmaceutical (Pty) Ltdactive7 Feb 2028
BENDAMUSTINE 100 mg MYLAN50/26/1063Viatris Healthcare (Pty) Ltdactive1 Jan 1900
BENDAMUSTINE 100 mg FRESENIUS50/26/0676Fresenius Kabi South Africa (Pty) Ltdactive1 Jan 1900
BENDAMUSTINE 25 mg FRESENIUS50/26/0675Fresenius Kabi South Africa (Pty) Ltdactive1 Jan 1900
BENDAMUSTINE 25mg MYLAN50/26/1062Viatris Healthcare (Pty) Ltdactive1 Jan 1900

Bendamustine Hydrochloride — SAHPRA Registration Details

SAHPRA (South Africa) has 13 registered products containing Bendamustine Hydrochloride, of which 13 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Bendamustine Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.